Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;42(1):11-24.
doi: 10.1080/01676830.2022.2122514. Epub 2022 Sep 30.

A review of surgical management of progressive myogenic ptosis

Affiliations
Review

A review of surgical management of progressive myogenic ptosis

Royce B Park et al. Orbit. 2023 Feb.

Abstract

Purpose: Surgical correction of myogenic ptosis is a sophisticated endeavor, as the disease is progressive and the post-operative course is prone to significant complications. We sought to review the literature for repair techniques in different types of myogenic ptosis.

Methods: A PubMed/MEDLINE literature search of publications pertaining to surgical outcomes of progressive myogenic ptosis repair was performed. Studies included were original retrospective studies with a minimum of four patients.

Results: A total of 27 articles were identified and divided by etiology of myogenic ptosis; either chronic progressive external ophthalmoplegia (CPEO), oculopharyngeal muscular dystrophy (OPMD), myasthenia gravis (MG), or mixed. Surgical techniques predominantly involved levator advancement, levator resection, frontalis sling, blepharoplasty, and Fasanella-Servat. Success rates ranged from 60.5% to 100%. Significant postoperative complications included ptosis recurrence, under-correction, over-correction, keratopathy, lagophthalmos, sling exposure, and sling infection.

Conclusion: Like surgical repair for other forms of ptosis, correction of progressive myogenic ptosis is guided by levator excursion. However, myogenic ptosis is especially challenging as it is characterized by worsening ptosis and the loss of protective corneal mechanisms. The goals of care with myogenic ptosis involves repairing ptosis just sufficiently to alleviate visual obstruction while avoiding adverse post-operative complications. This intentional under-correction subsequently increases susceptibility for ptosis recurrence. Myogenic ptosis repair therefore requires delicate balancing between function, sustained repair, and corneal protection.

Keywords: CPEO; MG; OPMD; myopathic ptosis; progressive myogenic ptosis.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTEREST

Dr. Vinay K. Aakalu: Patents owned by the Board of Trustees of the University of Illinois and equity ownership ViSo Therapeutics Inc. These do not pertain to the subject matter reported in this article.

References

    1. Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of Myogenic Ptosis 2002;109:9. - PubMed
    1. Seyhan N, Keskin M, Tosun Z, Savaci N. Surgical correction of ptosis in chronic progressive external opthalmoplegia. Eur J Plast Surg 2012;35:621–3. 10.1007/s00238-011-0574-1. - DOI
    1. Kang DH, Koo SH, Ahn DS, Park SH, Yoon ES. Correction of Blepharoptosis in Oculopharyngeal Muscular Dystrophy 2002;49:5. - PubMed
    1. Kisilevsky E, Freund P, Margolin E. Mitochondrial disorders and the eye. Surv Ophthalmol 2020;65:294–311. 10.1016/j.survophthal.2019.11.001. - DOI - PubMed
    1. Lane CM, Collin JR. Treatment of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthalmol 1987;71:290–4. 10.1136/bjo.71.4.290. - DOI - PMC - PubMed